{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:33:56Z","timestamp":1777034036347,"version":"3.51.4"},"reference-count":6,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To review the long-term corneal complications after high-dose external beam orbital radiotherapy given to patients for lacrimal gland carcinomas. The impact of prophylactic measures to improve long-term ocular surface health is also assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective case series.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Patients under the care of Moorfields Eye Hospital and receiving external beam radiotherapy for primary epithelial lacrimal gland carcinoma between 1975 and 2014.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective review of ophthalmic case notes at Moorfields Eye Hospital, and oncology and general physician records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>The occurrence of corneal perforation, and time to perforation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty-seven patients were included in this study, of whom nine (13%) developed corneal perforation at a median time of 10.4 months after radiotherapy (mean 35; range 3.2 months to 14.5 years); the majority (7\/9; 78%) perforated within 36 months of radiotherapy. The mean follow-up interval of the whole cohort was 8.2 years (median 4.6; range, 2 months to 30.7 years).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although most patients with globe-sparing treatment of lacrimal gland carcinoma did not suffer corneal perforation, they usually require long-term therapy to maintain the ocular surface. The high-dose external beam radiotherapy needed for lacrimal gland carcinoma can produce significant ocular surface morbidity, and the 13% incidence of corneal perforation was greatest in the first 3 years after irradiation.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311134","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T16:15:11Z","timestamp":1508429711000},"page":"882-884","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Corneal complications after orbital radiotherapy for primary epithelial malignancies of the lacrimal gland"],"prefix":"10.1136","volume":"102","author":[{"given":"Sri K","family":"Gore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P","family":"Plowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Dharmasena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H","family":"Verity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey E","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"2020050713013666000_102.7.882.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.7.401"},{"key":"2020050713013666000_102.7.882.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.09.056"},{"key":"2020050713013666000_102.7.882.3","first-page":"413","article-title":"The late effects of x-radiation on the cornea","volume":"56","author":"Blodi","year":"1958","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2020050713013666000_102.7.882.4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0420.2006.00822.x","article-title":"Ophthalmic and adnexal complications of radiotherapy","volume":"85","author":"Durkin","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"2020050713013666000_102.7.882.5","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00062-4"},{"key":"2020050713013666000_102.7.882.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000154235.64359.d3"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:56:12Z","timestamp":1601110572000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":6,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,6,24]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311134"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311134","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}